99%+ Purity | HPLC & Mass Spec Tested | Certificate of Analysis
Purpose Beyond Research
A portion of every order supports organizations focused on childhood cancer research and care. Your purchase contributes to advancing science and making a difference in families’ lives.
What You’ll Receive
Upon receipt, you will receive an airtight vial of lyophilized powder. To reconstitute the powder, you will require bacteriostatic water and a syringe, see Reconstitution Guide.
Product Description
Retatrutide is a novel investigational peptide being studied for its potential in metabolic regulation and weight management. As a triple agonist of the GLP-1, GIP, and glucagon receptors, it is of interest to researchers exploring synergistic effects on appetite control, energy expenditure, and glucose metabolism. Early studies suggest it may offer enhanced results compared to single-pathway peptides.
Key Research Features
• Triple receptor activation: GLP-1, GIP, and glucagon pathways
• Investigated for effects on weight regulation and energy balance
• Studied for potential benefits in glycemic control
Clinical Data:
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
Specifications
• Form: Lyophilized powder
• Purity: >99%
• Storage: Store dry at 2–8°C; refrigerate after reconstitution
• Intended Use: Laboratory research only; not for human consumption
99%+ Purity | HPLC & Mass Spec Tested | Certificate of Analysis
Purpose Beyond Research
A portion of every order supports organizations focused on childhood cancer research and care. Your purchase contributes to advancing science and making a difference in families’ lives.
What You’ll Receive
Upon receipt, you will receive an airtight vial of lyophilized powder. To reconstitute the powder, you will require bacteriostatic water and a syringe, see Reconstitution Guide.
Product Description
Retatrutide is a novel investigational peptide being studied for its potential in metabolic regulation and weight management. As a triple agonist of the GLP-1, GIP, and glucagon receptors, it is of interest to researchers exploring synergistic effects on appetite control, energy expenditure, and glucose metabolism. Early studies suggest it may offer enhanced results compared to single-pathway peptides.
Key Research Features
• Triple receptor activation: GLP-1, GIP, and glucagon pathways
• Investigated for effects on weight regulation and energy balance
• Studied for potential benefits in glycemic control
Clinical Data:
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
Specifications
• Form: Lyophilized powder
• Purity: >99%
• Storage: Store dry at 2–8°C; refrigerate after reconstitution
• Intended Use: Laboratory research only; not for human consumption
Image 1 of 1